U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
191551191551Daclizumab to Treat Wegener's GranulomatosisCompletedNo Results AvailableWegener's GranulomatosisDrug: Daclizumabhttps://ClinicalTrials.gov/show/NCT00040248
191552191552Magnesium Effects in ApheresisCompletedNo Results AvailableHealthyProcedure: magnesiumhttps://ClinicalTrials.gov/show/NCT00040235
191553191553Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian CancerRecruitingNo Results AvailableFamilial Ovarian Cancer|Familial Breast Cancer|BRCA1-associate Malignancies|BRCA2-associated Malignancieshttps://ClinicalTrials.gov/show/NCT00040222
191554191554JP-1730 to Treat Parkinson's DiseaseCompletedNo Results AvailableParkinson DiseaseDrug: JP 1730|Drug: IV Levodopa|Drug: IV Apomorphinehttps://ClinicalTrials.gov/show/NCT00040209
191555191555How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement PerformanceCompletedNo Results AvailableParkinson Diseasehttps://ClinicalTrials.gov/show/NCT00040196
191556191556OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.CompletedNo Results AvailablePancreatic CancerDrug: Tarceva (erlotinib HCl, OSI-774)https://ClinicalTrials.gov/show/NCT00040183
191557191557Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate CancerTerminatedNo Results AvailableProstatic NeoplasmsBiological: MVA-MUC1-IL2https://ClinicalTrials.gov/show/NCT00040170
191558191558Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.TerminatedNo Results AvailableHIV InfectionsDrug: ACH126-443 (Beta-L-Fd4C)https://ClinicalTrials.gov/show/NCT00040157
191559191559Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis BTerminatedNo Results AvailableChronic Hepatitis BDrug: ACH126, 433 (b-L-Fd4C)https://ClinicalTrials.gov/show/NCT00040144
191560191560Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED)TerminatedNo Results AvailableBile Duct Diseases|Biliary Tract Diseases|Gallbladder Diseases|Pancreatitis|Pancreatic DiseasesDrug: IL-10https://ClinicalTrials.gov/show/NCT00040131
191561191561Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous LeukemiaCompletedNo Results AvailableLeukemia, Myeloid, ChronicDrug: Zarnestra (R115777)|Drug: Gleevec (Imatinib mesylate)https://ClinicalTrials.gov/show/NCT00040105
191562191562A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic CancerCompletedNo Results AvailablePancreatic CancerDrug: Virulizin®https://ClinicalTrials.gov/show/NCT00040092
191563191563Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1Active, not recruitingNo Results AvailableCocaine-Related DisordersProcedure: Cocaine (IV)https://ClinicalTrials.gov/show/NCT00040066
191564191564Ondansetron for the Treatment of Methamphetamine Dependence - 1CompletedNo Results AvailableAmphetamine-Related DisordersDrug: Ondansetronhttps://ClinicalTrials.gov/show/NCT00040053
191565191565Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1Active, not recruitingNo Results AvailableAmphetamine-Related DisordersDrug: Bupropionhttps://ClinicalTrials.gov/show/NCT00040040
191566191566Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus RibavirinCompletedNo Results AvailableHepatitis C|Hepatitis C, ChronicDrug: thymalfasin (thymosin alpha 1) + PEGinterferon alfa-2a|Drug: placebo + PEGinterferon alfa-2ahttps://ClinicalTrials.gov/show/NCT00040027
191567191567Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal WomenTerminatedNo Results AvailableBreast NeoplasmsDrug: exemestanehttps://ClinicalTrials.gov/show/NCT00040014
191568191568Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial FibrillationCompletedNo Results AvailableAtrial FibrillationDrug: DTI-0009https://ClinicalTrials.gov/show/NCT00040001
191569191569Treatment of Multiple Sclerosis With Copaxone and AlbuterolCompletedNo Results AvailableAutoimmune Diseases|Multiple SclerosisDrug: Glatiramer acetate|Drug: Albuterol|Drug: Albuterol placebohttps://ClinicalTrials.gov/show/NCT00039988
191570191570Interactions Between HIV Protease Inhibitors and Calcium Channel BlockersCompletedNo Results AvailableHIV Infections|Cardiovascular Diseases|HypertensionDrug: Indinavir sulfate|Drug: Ritonavir|Drug: Amlodipine|Drug: Diltiazem HClhttps://ClinicalTrials.gov/show/NCT00039975
191571191571Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus RibavirinCompletedNo Results AvailableHepatitis C|Hepatitis C, ChronicDrug: thymalfasin (thymosin alpha 1)|Drug: PEGinterferon alfa-2ahttps://ClinicalTrials.gov/show/NCT00039962
191572191572Treatment of Binge Eating DisorderCompletedNo Results AvailableBulimia|ObesityBehavioral: Cognitive Behavior Treatment|Behavioral: Self Help|Behavioral: Partial Self Helphttps://ClinicalTrials.gov/show/NCT00039936
191573191573Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal HemoglobinuriaCompletedNo Results AvailableParoxysmal Hemoglobinuriahttps://ClinicalTrials.gov/show/NCT00039923
191574191574Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaCompletedNo Results AvailableNon-Hodgkin Lymphoma|Hodgkin Disease|ThrombocytopeniaDrug: (PN-152,243)/ PN-196,444https://ClinicalTrials.gov/show/NCT00039910
191575191575Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?Active, not recruitingNo Results AvailableAnemia|Cervix NeoplasmsDrug: NESP - Novel Erythropoiesis Stimulating Proteinhttps://ClinicalTrials.gov/show/NCT00039884
191576191576PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)CompletedHas ResultsHepatitis|Hepatitis C, Chronic|Fibrosis|Liver CirrhosisBiological: PegIntron (peginterferon alfa-2b; SCH 54031)|Drug: REBETOL (ribavirin; SCH 18908)https://ClinicalTrials.gov/show/NCT00039871
191577191577Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to HeparinCompletedNo Results AvailableThrombocytopenia|ThrombosisDrug: Argatrobanhttps://ClinicalTrials.gov/show/NCT00039858
191578191578MRI Language Studies in Young ChildrenCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00039845
191579191579ReoPro and Retavase to Restore Brain Blood Flow After StrokeCompletedNo Results AvailableCerebrovascular AccidentDrug: Abciximab (ReoPro) and Reteplase (Retavase)https://ClinicalTrials.gov/show/NCT00039832
191580191580Nerve Stimulation to Modify a Spinal ReflexCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00039819

* Görseller ve İçerik tekif hakkına sahip olabilir